GE HealthCare (GEHC) Tops Q3 EPS by 14c, Beats on Revenue

Go back to GE HealthCare (GEHC) Tops Q3 EPS by 14c, Beats on Revenue

GE HealthCare reports third quarter 2026 financial results

October 28, 2026 6:20 AM EDT

Delivers top- and bottom-line growth ahead of Company expectations and raises full-year 2026 guidance Revenue growth of 7.2%, and Organic revenue growth* of 6.2% Organic orders growth of 4.0%, book-to-bill of 1.03 times and backlog of $23.7 billion Net income margin of 11.1% and Adjusted earnings before interest and taxes (EBIT) margin* of 16.6%; diluted EPS of $1.36 grew 39.1% and Adjusted EPS* of $1.34 grew 25.1% Cash flow from operating activities of $907 million and Free cash flow* of $793 million

CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today reported financial results for the third quarter ended... More